tradingkey.logo
搜尋

NeuroOne Medical Technologies Corp

NMTC
添加自選
3.000USD
-0.040-1.32%
收盤 07/01, 16:00美東報價延遲15分鐘
26.11M總市值
虧損本益比TTM

NeuroOne Medical Technologies Corp

3.000
-0.040-1.32%

關於 NeuroOne Medical Technologies Corp 公司

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

NeuroOne Medical Technologies Corp簡介

公司代碼NMTC
公司名稱NeuroOne Medical Technologies Corp
上市日期Nov 09, 2012
CEORosa (David A)
員工數量17
證券類型Ordinary Share
年結日Nov 09
公司地址7599 Anagram Dr
城市EDEN PRAIRIE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編55344-7399
電話19524261383
網址https://nmtc1.com/
公司代碼NMTC
上市日期Nov 09, 2012
CEORosa (David A)

NeuroOne Medical Technologies Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

常見問題

NeuroOne Medical Technologies Corp的前五大股東是誰?

NeuroOne Medical Technologies Corp的前五大股東如下:Mr. David A. (Dave) Rosa

有多少機構持有NeuroOne Medical Technologies Corp(NMTC)的股份?

截至2026Q1,共有58家機構持有NeuroOne Medical Technologies Corp的股份,合計持有的股份價值約為2.36M,占公司總股份的28.07% 。與2025Q4相比,機構持股有所增加,增幅為-230396.00。